Healthcare Services

Gene Editing Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Gene Editing Market Between 2026 And 2030?

The gene editing market has seen rapid expansion in recent years. It is anticipated to increase from $10.31 billion in 2025 to $12.28 billion in 2026, growing at a compound annual growth rate (CAGR) of 19.0%. The historical growth in this market can be attributed to factors such as the discovery of CRISPR-Cas systems, significant academic gene editing research, the advancement of ZFN and TALEN technologies, the availability of research funding, and the expansion of molecular biology tools.

The gene editing market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $24.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.8%. This anticipated growth during the forecast period stems from factors such as the clinical implementation of gene editing therapies, favorable regulatory approvals, advancements in next-generation editing tools, a surge in industry investments, and the broadening scope of precision medicine. Key trends characterizing this period encompass the swift uptake of crispr-based technologies, the extended application of gene editing within cell line engineering, its growing utilization in agricultural and animal genetics, an increase in therapeutic gene editing research, and a heightened need for precise genome modification.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What Major Drivers Are Influencing Demand In The Gene Editing Market?

An anticipated increase in genetic disorders is projected to drive the expansion of the gene editing global market in the future. Genetic disorders are health conditions stemming from DNA abnormalities or mutations, which can be either inherited or arise spontaneously. These lead to diverse health problems, appearing at birth or later in life. Gene editing offers significant promise in addressing severe genetic illnesses like sickle cell disease, Huntington’s disease, ß-thalassemia, cystic fibrosis, Alzheimer’s, and Parkinson’s. As an illustration, the National Library of Medicine (NLM), a US medical library, reported in April 2023 that approximately 6.7 million Americans aged 65 and above are expected to have Alzheimer’s dementia (AD) in 2023. This figure is projected to rise to 13.8 million by 2060, unless significant medical advancements for AD prevention, slowing, or cure emerge. Consequently, the growing incidence of genetic disorders is anticipated to stimulate the gene editing market.

Which Market Segments Are Examined In The Gene Editing Market Study?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

What Major Market Trends Are Driving Changes In The Gene Editing Market?

Major companies in the gene editing markets are introducing innovative technologies, such as methods leveraging specialized cell-penetrating peptides, to gain a competitive advantage by offering improvements over existing techniques. This approach also holds potential for advancing cell therapies for conditions like cancer and other diseases. For example, in April 2023, Penn Medicine, a prominent US multi-hospital health system, identified that protein fragments typically used by certain viruses to enter cells can effectively transport CRISPR-Cas gene editing molecules into cells and their DNA-containing nuclei with remarkable efficiency and minimal cellular toxicity. Researchers believe this new technique will be especially valuable for modifying a patient’s own T cells and other cells for various cell therapies, including CAR T (chimeric antigen receptor T cell) therapy, which utilizes specifically altered immune cells from a patient to combat cancer. Overall, this novel method for genetically engineering cells promises substantial enhancements in speed, efficiency, and a reduction in cellular toxicity compared to current practices.

Who Are The Primary Competitors In The Gene Editing Market?

Major companies operating in the gene editing market are AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., ToolGen Inc., Mirus Bio LLC

Read the full gene editing market report here:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Gene Editing Market?

North America was the largest region in the gene editing market in 2025. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gene Editing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Browse Through More Reports Similar to the Global Gene Editing Market 2026, By The Business Research Company

Recombinant Dna Technology Global Market Report

https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report

Genes Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Advanced Drug Delivery Systems Global Market Report

https://www.thebusinessresearchcompany.com/report/advanced-drug-delivery-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795